{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:35Z","timestamp":1777870415976,"version":"3.51.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40620-014-0080-1","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T04:49:21Z","timestamp":1396500561000},"page":"659-666","source":"Crossref","is-referenced-by-count":15,"title":["Drug\u2013drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects"],"prefix":"10.1093","volume":"27","author":[{"given":"Edward","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Willsie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Winkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"80_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.ackd.2011.01.001","volume":"18","author":"KA Hruska","year":"2011","unstructured":"Hruska KA, Mathew S (2011) The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis 18:98\u2013104","journal-title":"Adv Chronic Kidney Dis"},{"key":"80_CR2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00041552-200111000-00003","volume":"10","author":"GA Block","year":"2001","unstructured":"Block GA (2001) Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Curr Opin Nephrol Hypertens 10:741\u2013747","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"80_CR3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"80_CR4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119\u20131127","journal-title":"JAMA"},{"key":"80_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27:220\u2013230","journal-title":"Blood Purif"},{"key":"80_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519\u2013530","journal-title":"Am J Kidney Dis"},{"key":"80_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNP74004","volume":"74","author":"P Geisser","year":"2010","unstructured":"Geisser P, Philipp E (2010) PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease. Clin Nephrol 74:4\u201311","journal-title":"Clin Nephrol"},{"key":"80_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","volume":"14","author":"O Hergesell","year":"1999","unstructured":"Hergesell O, Ritz E (1999) Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients. Nephrol Dial Transplant 14:863\u2013867","journal-title":"Nephrol Dial Transplant"},{"key":"80_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.08230811","volume":"8","author":"RP W\u00fcthrich","year":"2013","unstructured":"W\u00fcthrich RP, Chonchol M, Covic A, Gaillard S, Chong E, Tumlin JA (2013) Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J Am Soc Nephrol 8:280\u2013289","journal-title":"Clin J Am Soc Nephrol"},{"key":"80_CR10","doi-asserted-by":"crossref","first-page":"abstract SA-PO1","DOI":"10.1681\/ASN.2011111048","volume":"23","author":"J Floege","year":"2012","unstructured":"Floege J, Ketteler M, Rastogi A et al (2012) Efficacy and safety of PA21 in hyperphosphatemic CKD patients on dialysis. J Am Soc Nephrol 23:abstract SA-PO1103","journal-title":"J Am Soc Nephrol"},{"key":"80_CR11","first-page":"abstract TH-OR0","volume":"24","author":"S Sprague","year":"2013","unstructured":"Sprague S, Floege J, Covic A et al (2013) Efficacy of PA21, a novel iron-based phosphate binder, maintained to 52\u00a0weeks in dialysis patients with hyperphosphatemia. J Am Soc Nephrol 24:abstract TH-OR027","journal-title":"J Am Soc Nephrol"},{"key":"80_CR12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ackd.2010.03.005","volume":"17","author":"DE Rifkin","year":"2010","unstructured":"Rifkin DE, Winkelmayer WC (2010) Medication issues in older individuals with CKD. Adv Chronic Kidney Dis 17:320\u2013328","journal-title":"Adv Chronic Kidney Dis"},{"key":"80_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1525-139X.2009.00629.x","volume":"23","author":"NA Mason","year":"2010","unstructured":"Mason NA, Bakus JL (2010) Strategies for reducing polypharmacy and other medication-related problems in chronic kidney disease. Semin Dial 23:55\u201361","journal-title":"Semin Dial"},{"key":"80_CR14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpt1978233315","volume":"23","author":"BF Johnson","year":"1978","unstructured":"Johnson BF, O\u2019Grady J, Sabey GA, Bye C (1978) Effect of a standard breakfast on digoxin absorption in normal subjects. Clin Pharmacol Ther 23:315\u2013319","journal-title":"Clin Pharmacol Ther"},{"key":"80_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00044011-200525060-00004","volume":"25","author":"M Vaz-da-Silva","year":"2005","unstructured":"Vaz-da-Silva M, Loureiro AI, Nunes T et al (2005) Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions. Clin Drug Investig 25:391\u2013399","journal-title":"Clin Drug Investig"},{"key":"80_CR16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00615967","volume":"29","author":"B Beermann","year":"1986","unstructured":"Beermann B, Midskov C (1986) Reduced bioavailability and effect of furosemide given with food. Eur J Clin Pharmacol 29:725\u2013727","journal-title":"Eur J Clin Pharmacol"},{"key":"80_CR17","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","volume":"121","author":"M Sinsakul","year":"2012","unstructured":"Sinsakul M, Sika M, Koury M et al (2012) The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients. Nephron Clin Pract 121:c25\u2013c29","journal-title":"Nephron Clin Pract"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0080-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0080-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:13Z","timestamp":1777564693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/27\/6\/659\/8372306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0080-1","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}